Gregg L. Semenza: Difference between revisions

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
({{Scholia}})
Line 47: Line 47:
   
 
==References==
 
==References==
  +
{{Scholia}}
 
{{Reflist}}
 
{{Reflist}}
 
{{Nobel Prize in Physiology or Medicine}}
 
{{Nobel Prize in Physiology or Medicine}}

Revision as of 10:26, 7 October 2019

Gregg L. Semenza
Born (1956-07-01) July 1, 1956 (age 63)
Alma mater
AwardsNobel Prize in Physiology or Medicine (2019)

Gregg Leonard Semenza (born July 1, 1956) is the C. Michael Armstrong professor of pediatrics, radiation oncology, biological chemistry, medicine, and oncology at the Johns Hopkins University School of Medicine. He serves as the director of the vascular program at the Institute for Cell Engineering.[1] He is a 2016 recipient of the Lasker Award for Basic Medical Research.[2] He is known for his discovery of HIF-1, which allows cancer cells to adapt to oxygen-poor environments. He received the 2019 Nobel Prize in Physiology or Medicine for "discoveries of how cells sense and adapt to oxygen availability". [3]

He studied beta thalassemia while doing his PhD at the University of Pennsylvania.[3]

Awards

References

  1. ^ "Gregg L. Semenza, M.D., Ph.D."
  2. ^ Foundation, Lasker. "Oxygen sensing – an essential process for survival - The Lasker Foundation". The Lasker Foundation.
  3. ^ a b "Johns Hopkins geneticist Gregg Semenza wins Lasker Award for insights into how cells sense oxygen". 13 September 2016.
  4. ^ "Gregg L. Semenza". Institut de France. Grands Prix des Fondations. 2015-04-21. Retrieved 2017-12-12.